MedTrace Logo

Gene Analysis and Treatment Optimization in Chinese Homozygous Familial Hypercholesterolemia

NCT01878604 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2017-02-20

Study results available
· View outcomes & findings →

Summary

Identify new or novel genes which may impact on cholesterol level, and establish the relationship between those gene mutations with atherosclerosis, as well as responses to lipid-lowering drugs.

Conditions

  • Homozygous Familial Hypercholesterolemia

Interventions

GENETIC

Gene analysis

Gene analysis

OTHER

Historical data of lipid-lowering drug administration

Collecting historical data of lipid-lowering drug administration

OTHER

Historical data of plasma lipids, xanthoma changes

Collecting historical data of plasma lipids and xanthoma changes

Sponsors & Collaborators

  • Central South University

    lead OTHER

Principal Investigators

  • Shuiping Zhao, Doctor · Central South University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-10-31
Primary Completion
2014-10-31
Completion
2015-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01878604 on ClinicalTrials.gov